We will introduce, within our ‘Covid at home’ protocol, the use of hydroxychloroquine; it can be used by doctors according to science and conscience.
Category: Solutions
Adjunct Prof John SkerrittDeputy SecretaryHealth Products Regulation GroupJohn.Skerritt@health.gov.auGPO Box 9848, Canberra, ACT Dear Professor Skerritt,We are writing to express our concerns regarding the role of the Therapeutics and Goods Administration (TGA) in banning Hydroxychloroquine (HCQ) for the use in Covid-19 Illness presentations and thereby criminalising its use by doctors inthis setting.As Deputy Secretary of the […]
Source: Filipe Rafaeli Author: Filipe Rafaeli Read PART ONE here Scientists have already discovered what to do for the hydroxychloroquine to work also in critically ill patients A good part of the media confusion is that the immense part of the studies done with hydroxychloroquine, with or without the combination with azithromycin, occurred in critically ill […]
Source: Filipe Rafaeli Author: Filipe Rafaeli If you don’t want to die in this pandemic, read it to the end! Here I do a historical reflection on science and I show all the irrefutable evidence of the functioning of the taboo medicine. “He was capable of being so kind to the children, to have them […]
In a recent AMA memo (resolution 509) the AMA officially reversed its stance on HCQ, but disappointingly, the AMA ultimately voted against resolution 509.
The AMA, in a surprising move, has officially rescinded a previous statement against the use of Hydroxychloroquine (HCQ) in the treatment of COVID-19.
Source: Collective Evolution Author: Arjun Walia IN BRIEF The Facts: Dr. Harvey Risch, MD, Ph.D., Yale Professor of Epidemiology and Public Health provides evidence-based testimony at a US Senate hearing on early outpatient HCQ treatment for high-risk Covid-19 patients. Reflect On: Why have such treatments been ridiculed when so many papers, doctors, and experts stand […]
The evidence provided by AIFA was not enough to limit the individual doctors’ decisional autonomy; the ban on hydroxychloroquine was reversed on 11 December.
Source: ANSA The III Section of the Council of State accepted, as a precautionary measure, the appeal of a group of general practitioners and suspended AIFA’s note of 22 July last which prohibited off-label prescription (i.e. for a use not provided for in the leaflet) hydroxychloroquine for the fight against Covid. “The continuing uncertainty about […]
Source: RMC101 Media Group A cure that works, which has saved many lives, but which is not recognized by official protocols. It’s battle over hydroxychloroquine. A difficult name to pronounce, but which is at the center of an international battle, with more and more doctors, including many Italians, convinced of the goodness of its use, and dozens of […]
Source: Craig Kelly MP “My ’90 second’ speech today:” “Following an extraordinary US Senate Committee hearing overnight, especially the impassioned plea of Associate Professor Dr Pierre Kory, I again call on our National Covid Clinical Evidence Taskforce to look at the evidence, and immediately – not next week or after Christmas – immediately reverse their […]
Ivermectin. It basically obliterates transmission of this virus. Early treatment is key. That is a scientific recommendation based on mountains of data
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.
Source: Affaritaliani Author: Monica Camozzi Interview with Andrea Stramezzi, one of the many doctors who silently treats – and heals – many coronavirus patients – that’s how. “New Microbes and New Infections” magazine Vol. 38 Nov 2020, published a literature review work on Hydroxychloroquine and found that 100% of the jobs in which HCQ were […]
Categories
Africa Algeria Andorra Argentina Australia Bahrain Bangladesh Belgium Bosnia Brazil Bulgaria Cambodia Cameroon Canada China Clinical Trials Costa Rica Cuba Czechoslovakia Denmark Ecuador Egypt El Salvador Finland France Germany Ghana Global Greece Guyana Honduras Hungary Hydroxychloroquine India Indonesia Iran Ireland Israel Italy Japan Jordan Kenya Laos Lebanon Malaysia Mauritia Medical Study Mexico Morocco Nepal New Zealand Nigeria Norway Observational Study Official Oman Pakistan Panama Paraguay Peer reviewed Peru Philippines Poland Portugal Prophylaxis Qatar RESEARCH Romania Russia Saudi Arabia Scotland Senegal Serbia Singapore South Africa South Korea Spain Sweden Switzerland Syria Taiwan Thailand The Netherlands Treatment Tunisia Turkey UAE Uganda UK Ukraine US Venezuela Vietnam
A massive hydroxychloroquine meta-analysis (156 studies) has just been updated (version 28!).It says that HCQ works beyond all statistical doubt.
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version 28, December 4, 2020) • HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 156 studies to date is estimated to be 1 in 36 trillion (p = 0.000000000000028). • Early treatment is […]
Source: Research Square. Augusto Di Castelnuovo, Mediterranea Cardiocentro, NapoliSimona Costanzo, Department of Epidemiology and Prevention, IRCCS Neuromed, PozzilliAntonio Cassone, Polo della genomica, genetica e biologia, Università di SienaRoberto Cauda ,Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica S. Cuore RomaGiovanni de Gaetano ,Department of Epidemiology and Prevention, IRCCS Neuromed, PozzilliLicia Iacoviello, Department of Epidemiology and […]
Source: MedRxIV David M. Wiseman, Pierre Kory, Samir A Saidi, Dan Mazzucco doi: https://doi.org/10.1101/2020.11.29.20235218 Abstract BACKGROUND A recent trial (NCT04308668) found that post-exposure prophylaxis with hydroxychloroquine (HCQ) was associated with a reduced incidence of Covid-19 by 17% overall; 36% in younger subjects, 31% in household contacts and 49% given within one day. To understand these trends, we prospectively re-analyzed the released dataset. METHODS Our […]
Chloroquine / hydroxychloroquine could treat COVID-19 infection
Source: Sky News Interview with: Dr Peter McCullough Hydroxychloroquine really works says Professor of Medicine Dr Peter McCullough, describing the treatment as “the most widely used therapeutic” to treat COVID-19 in the world. “The chances that it doesn’t work are calculated to be one in 17 billion,” he told Sky News. “There’s no controversy over […]
Source: Nature Panama has gone one step further than other Latin American countries that use the drug ivermectin against COVID-19. The government has approved this drug and hydroxychloroquine, and is stockpiling both. Panama has purchased 2,900,000 doses of hydroxychloroquine and 450,000 doses of ivermectin, to be distributed as part of a self-treatment kit to people […]
Source: The Blaze Author: CHRIS PANDOLFO A peer-reviewed study analyzing the effectiveness of a triple drug cocktail including hydroxychloroquine in treating COVID-19 patients found that the treatment was effective and that it significantly reduced hospitalization and mortality rates for those in the treatment group. The study, authored by the controversial Dr. Vladimir Zelenko in partnership with two German doctors, […]
I want some doctor somewhere to explain to me, and if they can explain to me why we’re not treating early I would gladly offer them a million dollars.
My point is to talk about the bill I championed through Congress – Right to Try. Now, the current situation for example with hydroxychloroquine is not a prime example of Right to Try because hydroxychloroquine is a fully approved drug. What Right to Try says is that if a drug has gone through the first two stages, of FDA approval, so it’s been proven safe, but hasn’t gone through the final efficacy approval, a patient and a doctor still have the right to try that if there are no other available treatments.
Source: AAPS Online Senior Editor:Jane Orient, MD, Internal Medicine Physician, Executive Director,Association of American Physicians and Surgeons,President, Doctors for Disaster PreparednessConsulting Editor:Peter A. McCullough, MD, MPH, FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSAInternist, Cardiologist, and Epidemiologist,President, Cardiorenal Society of AmericaEditor/Writer:Elizabeth Lee Vliet, MD, Preventive MedicinePast Director, Association of American Physicians and Surgeons,Member of AAPS Editorial […]
Source: America’s Frontline Doctors THIS IS NOT MEDICAL ADVICE. Every situation is unique, and every person must check with his or her own physician, especially if you are taking any other medications. Do not write to any of the doctors about your specific medical situations; they will not answer. Treatment Protocol Dr. Peter McCullough Prophylactic […]
Source: swprs.org On the Treatment of Covid-19 Updated: November 16, 2020; Published: July 2, 2020 Immunological and serological studies show that most people develop only mild or moderate symptoms when infected with the new coronavirus, while some people may experience a more pronounced or critical course of the disease (read more). Based on the available scientific […]
Results obtained in the prophylaxis of Q fever indicate that chloroquine/hydroxychloroquine can be successfully used in the clinical management of infections other than malaria.
Source: PiaCenza24 Author: FPG Home anti-Covid therapy with Hcl: solution to lockdown found. Solution already active in Piedmont. And from the scientific community comes an appeal to Bonaccini. “In fact, a treatment protocol similar to the Piedmontese one was carried out in Rimini in April – with 350 patients treated at home with HCL (hydroxychloroquine) and monitored by […]
Source: Science Direct Tran Duc Anh Ly, Didier Zanini, Vincent Laforge, Sylvie Arlotto, Stephanie Gentile, Helene Mendizabal, Michael Finaud, David Morel, Olivier Quenette, Priscilla Malfuson-Clot-Faybesse, Alain Midejean, Phuc Le-Dinh, Gérard Daher, Berengere Labarriere, Anne-Marie Morel-Roux, Alain Coquet, Patrick Augier, Philippe Parola, Eric Chabriere, Didier Raoult, Philippe Gautret,Pattern of SARS-CoV-2 infection among dependant elderly residents living […]
Source: Science Direct Eman Sheshah, Shaun Sabico, Rashed M. Albakr, Anmar A. Sultan, Khalaf S. Alghamdi, Khaled Al Madani, Hadil A. Alotair, Nasser M. Al-Daghri,Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia,Diabetes Research and Clinical Practice,2020,108538,ISSN 0168-8227,https://doi.org/10.1016/j.diabres.2020.108538. Abstract This retrospective study aimed to […]
Source: Science Direct Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P,Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers, New Microbesand New Infections, https://doi.org/10.1016/j.nmni.2020.100813. Abstract Hydroxychloroquine (HCQ) exerts antiviral effects through several mechanisms. Our initial experience suggests that HCQ could be used for prophylaxis of COVID-19 infection in health care workers […]
Source: News Max Author: By Brian Trusdell Photo: Getty The anti-malarial drug promoted by the US President as a treatment for COVID-19 — and derided by his critics — has been found to help outpatients with the disease, a new peer-reviewed study says. Only 3% of patients that took hydroxychloroquine along with zinc and the antibiotic azithromycin […]
Source: Rheumetology Network Author: Katie Robinson Patients with systemic lupus erythematous (SLE) who take hydroxychloroquine do not have any differences in their corrected QT (QTc) intervals on electrocardiogram (EKG), even if they have chronic kidney disease (CKD), according to researchers reporting at the annual meeting of the American College of Rheumatology on Monday. Patients with […]
Source: World Doctors Alliance Data updated daily.Last update 09.11.2020 TOTAL SIGNATURES SO FAR: 41,625 Website data since launch (10.10.2020):Total pageviews: 855,989Total unique visitors: 362,845 INTRODUCTION We were told initially that the premise for lockdown was to ‘flatten the curve’ and therefore protect the NHS from being overwhelmed. It is clear that at no point was […]
Source: Le Point Mister President, Please allow me to add my voice, not to the concert of invective triggered by your decisions of October 28 , but to the marginal choir which still strives to appeal to your capacities for analysis, social benevolence and self-protection. . When a Minister of Health rushes into the National Assembly, ordering “Get out […]
Source: ACTU Toulouse Author: Hugues-Olivier Dumez Philippe Douste-Blazy is the author of a book against the State facing the crisis. In an interview for Actu Toulouse, he reaffirms in passing his support for Didier Raoult. His word counts in the public debate. The former mayor of Toulouse , between 2001 and 2004, Philippe Douste-Blazy , was several times Minister of Health […]
We should learn from the countries that have been using the drug. The dramatic fall in death rates that occurred after hydroxychloroquine treatment was initiated in countries like India, Brazil and Ecuador can no longer be ignored. To do so, and to continue to interfere with a doctor’s right to prescribe HCQ to their patients, is reckless and immoral.
Of the whole study group (RA and SLE), 54% used hydroxychloroquine and 44% had QTc lengths of more than 440 milliseconds. They found that the adjusted QTc length among hydroxychloroquine users was comparable to those who did not use the drug.
Source: Journal of Marine Medical Society Date of Submission 23-Aug-2020 Date of Decision 18-Sep-2020 Date of Acceptance 29-Sep-2020 Date of Web Publication 06-Nov-2020 Correspondence Address:Vivek Hande,INHS Asvini, Colaba, Mumbai, MaharashtraIndia Source of Support: None, Conflict of Interest: None DOI: 10.4103/jmms.jmms_115_20 Abstract Background: Health-care workers (HCWs) are at high risk of acquiring COVID-19. Hydroxychloroquine (HCQ) possesses in vitro antiviral activity and inhibits […]
Source: Science Direct Dr. Deba PrasadDhibarMD(Assistant Professor)aDr. NavneetAroraMD(Senior Resident)aDr. ArpitKakkarDNB(Senior Resident)aDr. NeerajSinglaMD(Assistant Professor)bDr. RitinMohindraMD(Assistant Professor)bDr. VikasSuriMD(Additional Professor)bDr. AshishBhallaMD(Professor)bDr. NavneetSharmaMD(Professor)bDr. Mini PSinghMD(Professor)cDr. AjayPrakashPhd(Assistant Professor)dDr. LakshmiPVMMD(Professor)eDr. BikashMedhiMD(Professor)d Highlights This study, which to our knowledge is the only clinical trial that was dedicated to evaluating the efficacy of HCQ as post-exposure prophylaxis (PEP) to prevent COVID-19 in asymptomatic, […]